DrugPatentWatch Database Preview
Barr Labs Inc Company Profile
What is the competitive landscape for BARR LABS INC, and what generic and branded alternatives to BARR LABS INC drugs are available?
BARR LABS INC has seventeen approved drugs.
There are two tentative approvals on BARR LABS INC drugs.
Summary for Barr Labs Inc
| US Patents: | 0 |
| Tradenames: | 16 |
| Ingredients: | 15 |
| NDAs: | 17 |
Drugs and US Patents for Barr Labs Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barr Labs Inc | MINOCYCLINE HYDROCHLORIDE | minocycline hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 065485-007 | Apr 26, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Barr Labs Inc | DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE | amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 076536-005 | Feb 12, 2013 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Barr Labs Inc | OLANZAPINE | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 077243-003 | Jan 30, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Barr Labs Inc | ESTRADIOL | estradiol | TABLET;ORAL | 040197-002 | Oct 22, 1997 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Barr Labs Inc | ESTRADIOL | estradiol | TABLET;ORAL | 040197-003 | Oct 22, 1997 | AB | RX | No | Yes | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
